Trial intelligence / Profile preview

Effect of intravenous lactate on cerebral blood flow during hypoglycemia in type 1 diabetes

2018-000684-82Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Sodium lactate in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Change in regional thalamic cerebral blood flow during hypoglycemia. Started Mar 2018; status: completed.

02

Drugs

Sodium lactate
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2018-000684-82.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000684-82.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call